They also found that silencing fatty acid synthase (FASN) reversed the effects of hyperglycemia on the levels of EMT markers leading to increased expression of E-cadherin and decreased the expression of vimentin and fibronectin. The gene discussed is FASN; the disease is Hyperglycemia.